• Krolick K.A. (2006)  Muscle-Derived Nitric Oxide Synthase Expression, Differences Associated With Muscle Fiber-type, and Disease Susceptibility in a Rat Model of Myasthenia Gravis.  Clin. Immunol., 121:286-293.
• Garcia, Y.R. and Krolick, K.A.   (2004)   Short-circuiting autoimmune disease by target-tissue-derived nitric oxide. Clin Immunol. 113:74-80.
• Garcia, Y.R., Pothitakis, J.C., and Krolick, K.A.  (2003)  Myocyte production of nitric oxide in response to AChR-reactive antibodies in two inbred rat strains may influence disease outcome in experimental myasthenia gravis.   Clin. Immunol., 106:116-126.
• Reyna-Reyes, S., Stegall, T. and Krolick, K.A.  (2002)   Muscle responds to an antibody reactive with the acetylcholine receptor by up-regulating monocyte chemoattractant protein 1: a chemokine with the potential to influence the severity and course of experimental myasthenia gravis.   J. Immunol., 169:1579-1586.
• Garcia, Y.R., May, J.J., Green, A.M. and Krolick, K.A.  (2001)   Acetylcholine receptor-reactive antibody induces nitric oxide production by a rat skeletal muscle cell line: influence of cytokine environment.   J. Neuroimmunol., 120:103-111.
• Stegall, T. and Krolick, K.A.  (2001)   Myocytes respond in vivo to an antibody reactive with the acetylcholine receptor by upregulating interleukin-15: an interferon-gamma activator with the potential to influence the severity and course of experimental myasthenia gravis.   J. Neuroimmunol., 119:377-386.<
• Reyes-Reyna, S.M. and Krolick, K.A.  (2000) Chemokine production by rat myocytes exposed to interferon-gamma.  Clin. Immunol., 94:105-113.
• Stegall, T. and Krolick, K.A.  (2000)  Myocytes respond to both interleukin-4 and interferon-gamma: cytokine responsiveness with the potential to influence the severity and course of experimental myasthenia gravis.  Clin. Immunol., 94:133-139.
• Stegall, T. and Krolick, K.A.  (2000)  A monoclonal lewis rat myocyte line that responds to interferon-gamma: responsiveness with the potential to influence subsequent interactions with the immune system.  Clin. Immunol., 94:125-132.
• Krolick K.A., Zoda T.E. and Thompson P.A.  (1994)  Examination of characteristics that may distinguish disease-causing from benign AChR-reactive antibodies in experimental autoimmune myasthenia gravis.  Adv. Neuroimmunol., 4:475-493.

---